[Effects of combination chemoradiotherapy with daily low-dose CDDP for esophageal cancer--results of a randomized trial]
- PMID: 9388519
[Effects of combination chemoradiotherapy with daily low-dose CDDP for esophageal cancer--results of a randomized trial]
Abstract
Between 1994 and 1996, 24 patients with esophageal carcinoma were entered in a randomized clinical trial comparing radiotherapy (RT) only (arm A) versus RT and a daily low dose of CDDP (5 mg/m2) (arm B). For arm B group, CDDP was injected within 30 min after irradiation. All patients were irradiated with a total dose of 60 Gy /30fr. at first, and some patients were boosted. An overall response rate of 75.0% (complete response rate of 25.0%) was observed in arm A and 91.7% (complete response rate of 16.7%) in arm B, respectively. The survival rate at 1 year was 23.8% in arm A and 40.0% in arm B. Median survival time was 7 months in arm A and 9 months in arm B. Toxicity was acceptable and no significant difference was noted between arm A and arm B.
Similar articles
-
Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).Jpn J Clin Oncol. 2004 Oct;34(10):615-9. doi: 10.1093/jjco/hyh107. Jpn J Clin Oncol. 2004. PMID: 15591460 Clinical Trial.
-
Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.Anticancer Res. 1999 Sep-Oct;19(5C):4463-7. Anticancer Res. 1999. PMID: 10650793
-
Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36. doi: 10.1016/j.ijrobp.2004.03.033. Int J Radiat Oncol Biol Phys. 2004. PMID: 15380576
-
Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.J Surg Oncol. 2005 Jun 15;90(4):209-19. doi: 10.1002/jso.20259. J Surg Oncol. 2005. PMID: 15906363 Clinical Trial.
-
Why Concurrent CDDP and Radiotherapy Has Synergistic Antitumor Effects: A Review of In Vitro Experimental and Clinical-Based Studies.Int J Mol Sci. 2021 Mar 19;22(6):3140. doi: 10.3390/ijms22063140. Int J Mol Sci. 2021. PMID: 33808722 Free PMC article. Review.
Cited by
-
Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences.World J Surg. 2006 Feb;30(2):183-90. doi: 10.1007/s00268-005-7861-6. World J Surg. 2006. PMID: 16425075
-
Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.Strahlenther Onkol. 2010 Jul;186(7):374-81. doi: 10.1007/s00066-010-2137-y. Epub 2010 Jun 24. Strahlenther Onkol. 2010. PMID: 20582393
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical